Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine.
D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use*; D004357:Drug Synergism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D015122:Mercaptopurine / Q000627:therapeutic use*; D051381:Rats
D000963:Antimetabolites; D001391:Azo Compounds; D015122:Mercaptopurine